Lipogen Partners with Xenesta to Market Brain Health Supplement
14 Sep 2016 --- Lipogen, Ltd. has granted Xenesta Inc., global exclusive rights for marketing a dietary supplement product based on Lipogen PSPA. The new product will be marketed under Xenesta’s brand name. Lipogen PSPA, a new, patent-protected solution for stress management and brain health support, will be marketed through Xenesta’s network marketing (MLM) channel.
Xenesta’s PSPA supplement is natural, vegetarian, and contains no preservatives or artificial colors. It’s also vegan-friendly and contains blend of phosphatidylserine (PS) and phosphatidic acid (PA).
“The new supplement is scheduled for launch in fall of 2016 in the US market, targeting people aged 20-65 who feel stressed at their workplace or in daily life,” says Kyl Smith, DC, President and CEO of Xenesta.
“I’m impressed with the growing body of science that shows how Lipogen’s phospholipids can be beneficial for consumers, especially Millennials who live stressful lifestyles. The double-blind, placebo-controlled trials have verified the efficacy and safety of their unique technologies.”
In 2001, Dr. Smith, filed a Health Claim Petition for the brain nutrient phosphatidylserine that was approved by the U.S. Food and Drug Administration (FDA) as a qualified health claim. He is also the author of the acclaimed Brighter Mind, a book that shatters myths about nutrition and medicine as it relates to brain function, laying out four steps for naturally “supercharging” brain health.
David Rutenberg, CEO for Lipogen said, “We are excited to collaborate with Dr. Smith and develop a direct channel to reach US consumers.”
He continued, “His reputation and know-how in brain health, particularly in phosphatidylserine, is valuable for our partnership and the success of Lipogen PSPA to serve the stress management market. Today’s consumers are concerned about product source and safety, and together we will be able to fulfill the consumers trust.”
Lipogen PSPA has been successfully demonstrated in controlled clinical trials to improve the body’s stress response under psychological and socially demanding conditions, as measured by lower levels of cortisol, a catabolic stress hormone.
Further studies have revealed that PS helps improve the brain functions that decline with age, specifically, with memory and cognitive function.
The new dietary supplement will come in packaging that provides a monthly supply of the daily 400 mg PS + 400 mg PA serving, amounts demonstrated to have optimal results in clinical research.
